5 Stocks to Watch: Week of 3/10/2025

The markets were volatile last week, but there’s always something with strong potential. We’ve sifted through thousands of stocks to find you some of the most promising picks for the week ahead. A few highlights?

• CarGurus Inc (NASDAQ: CARG) is one of the top 2% of stocks we track (find out why)
• Looking for a stock with positive sentiment? Look no further than Huron Consulting Group Inc (NASDAQ: HURN)
• Remitly Global Inc (NASDAQ: RELY) has had a heck of a year — and it’s not over 
• BioMarin Pharmaceutical Inc (NASDAQ: BMRN) is a biotech with strong fundamentals (really)
• Nutanix Inc (NASDAQ: NTNX) has incredible growth potential, according to top-rated analysts

Let's get to it.

P.S. Love the charts in this post? We use TradingView Pro.

1. BioMarin Pharmaceutical Inc (NASDAQ: BMRN)

A lot of us tend to reflexively run for the hills at the mention of biotech stocks — but BioMarin has been in business for 27 years. More to the point, in that time, the company has risen to a $13.5 billion market cap — this isn’t some ambitious yet risky startup. With a robust pipeline of treatments aimed at rare diseases and a standout performance in 2024’s last quarter, BioMarin is increasingly looking like one of the best biotech bets in the market.

Zen Rating: A (Strong Buy) — see full analysis >  

Recent Price: $71.19  — get current quote > 

Max 1-year forecast:  $126.00

Why we’re watching:

• At present, 19 equity researchers issue ratings for BMRN. The Buy and Hold ratings stand evenly matched, with 5 analysts apiece — but the 9 Strong Buy ratings steal the show. See the ratings
• Eliana Merle of UBS (a top 26% rated analyst) reissued a Strong Buy rating on BioMarin stock on February 20. In addition, she increased her 12-month price forecast from $109 to $113.
• Merle’s revision came after the company’s Q4 report, which saw sales, earnings, and revenues come in above estimates.
• Looking ahead, the analyst said that Voxzogo still has plenty of room to grow in terms of greater penetration of the achondroplasia market and long-term expansion.
• Merle detailed that UBS believes the opportunity for Voxzogo in indications beyond achondroplasia remains significantly underappreciated and could be $5B+.
• With an overall Zen Rating of A, BMRN stock is in good company — stocks that earn this distinction have provided an average annual return of 32.52%.
• Value, in which the stock ranks in the top 4% of the more than 4,600 equities that we track, is BioMarin’s strong suit — but we wouldn’t discount its Financial rating either, as it is in the 92nd percentile in that category. (See all 7 Zen Component Grades here >)

2. Remitly Global Inc (NASDAQ: RELY)

Originally built for immigrants sending money home, Remitly Global Inc is changing the landscape of cross-border payments. The platform has managed to strike a careful balance between security, speed, and accessibility through low fees. Now operating in more than 170 countries, the company is well-positioned to capture significant growth on account of the global trend of financial inclusion.

Zen Rating: A (Strong Buy) — see full analysis >  

Recent Price: $22.22   — get current quote > 

Max 1-year forecast:  $33.00

Why we’re watching:

• 4 out of a total of 7 analysts rate RELY stock a Strong Buy — the remaining 3 ratings are split between 2 Buys and a lone Hold. See the ratings
• JP Morgan equity researcher Tien-tsin Huang (a top 13% rated analyst) reaffirmed a Strong Buy rating on February 20, following Remitly Global’s Q4 and FY 2024 report. The analyst raised his price target on Remitly stock from $21 to $30.
• Huang highlighted that the results were "strong" and that management raised its guidance from its preliminary outlook last quarter.
• The analyst told investors to expect Remitly Global to be a "top Fintech grower" in 2025 and predicted that management's guidance could prove conservative.
• Our proprietary quant rating system has ranked RELY in the top 5% of stocks when evaluating 115 factors — indicating a high likelihood of beating the market..
• RELY stock is a rare case, in that it has 3 different Component Grades rated A, namely Sentiment, Growth, and Artificial Intelligence. If we had to pick one of these to highlight, it would have to be Sentiment — a category in which the company ranks in the top 1% of stocks tracked by our system. (See all 7 Zen Component Grades here >)

3. Nutanix Inc (NASDAQ: NTNX) 

Nutanix makes enterprise IT much less of a hassle than it usually is. This is achieved by integrating compute, storage, and networking into one seamless platform — scalable, flexible, and easy to use. With a double beat in the company’s latest earnings call, and seemingly endless demand for data centers, the future appears bright for this week’s last entry.

Zen Rating: A (Strong Buy)  — see full analysis >  

Recent Price: $77.10   — get current quote > 

Max 1-year forecast:  $100.00

Why we’re watching:

• NTNX stock is a consensus Strong Buy — out of a total of 11 analysts, 5 rated the stock a Strong Buy, while the remaining 6 ratings are divided between 4 Buys and 2 Holds. See the ratings
• After the company’s Q2 2025 earnings, Barclays equity researcher Tim Long (a top 3% rated analyst) hiked his price target on Nutanix stock from $87 to $94, and maintained a Strong Buy rating, citing increased guidance. 
• The analyst said that "Nutanix's market share gain story remains intact," taking a positive view of the company's deal activity for 2025 and beyond.
• James Fish of Piper Sandler (a top 18% rated analyst) concurred — and increased his 12-month price forecast for NTNX stock from $83 to a more modest $88.
• Fish highlighted a major acceleration in lead metrics, sales increases, free cash flow moving higher, and net revenue retention (NRR) stabilization as the main drivers behind his decision.
• With an overall Zen Rating of A, NTNX belongs to a select class of equities identified as having a high likelihood of outperforming the wider market. On average, stocks in this class have provided an annual return of 32.52% since the early 2000s.
• Nutanix earns high marks in two categories — the stock’s Growth and Sentiment Component Grade ratings are both A. In terms of Growth, NTNX ranks in the top 1% of stocks we track — while in terms of Sentiment, it is rated in the 95th percentile. (See all 7 Zen Component Grades here >)

4. CarGurus Inc (NASDAQ: CARG)

When it comes to used cars, whether you’re buying or selling, CarGurus is there to connect you with the best deals. With a history stretching back to 2006, one of the US’s most visited automotive marketplaces has quite a hefty checkbook at its disposal. To boot, the company’s recently had a fairly good earnings call — and the Street is quite confident that there’s a lot of upside to be had here.

Zen Rating: A (Strong Buy) — see full analysis >  

Recent Price: $32.46 — get current quote > 

Max 1-year forecast:  $45.00

Why we’re watching:

• In total, 9 analysts track CARG stock — there’s an even division at play between 4 Strong Buy and 4 Buy ratings, with a lone Hold rating to round everything off. See the ratings
• Notably, the average 12-month price forecast for CarGurus shares implies a hefty 30.67% upside from current prices.
• Following the release of the company’s Q4 and FY 2024 report, JP Morgan’s Rajat Gupta (a top 10% rated analyst) maintained an earlier Strong Buy rating.
• The researcher adjusted their price target from $42 from $40, calling the quarter’s results slightly better than expected to in-line.
• According to the analyst, CarGurus' continued success in the market was driven by its steady progress on both current and future product initiatives as "it gets deeper into dealer workflows."
• CARG carries an overall Zen Rating of A — in fact, it is in the top 2% of the stocks that we track.
• The stock’s Growth Component Grade rating is a particularly strong point — in this category, CarGurus stock is in the 97th percentile. With that being said, even that impressive achievement pales in comparison to the marketplace’s strength when it comes to Financials rating — in which it ranks in the top 1%. (See all 7 Zen Component Grades here >)

5. Huron Consulting Group Inc (NASDAQ: HURN)

Strategic consulting sure sounds important — although like many similar turns, it tends to be overused as a buzzword. Huron Consulting Group’s services, however, are the real deal. When businesses need help scaling, streamlining, innovating or transforming, Huron is who they call. Well, to be specific, the company focuses on healthcare, education, and finance businesses in particular — but if anything, that’s only another plus.

Zen Rating: A (Strong Buy) — see full analysis >  

Recent Price:  $147.88 — get current quote > 

Max 1-year forecast:  $167.00

Why we’re watching:

• HURN stock has flown relatively under the radar. While only 3 analysts track the stock and issue ratings for it, those 3 ratings are divided between 2 Strong Buys and 1 Buy. See the ratings
• Benchmark’s Bill Sutherland (a top 24% rated analyst) maintained a Strong Buy rating following the company’s Q4 earnings, and increased his price target for HURN from $140 to $165.
• Looking ahead, the analyst said that "the macro set up is increasingly compelling, particularly in healthcare, with the potential emergence of changes in clinical reimbursement models, reduced NIH funding levels for research and stricter eligibility for Medicaid patients."
• On the same day, Tobey Summer of Truist Securities (a top 8% rated analyst) also reiterated a Strong Buy rating, while hiking his price forecast for HURN stock from $140 to $165.
• The Truist Securities researcher added that "healthcare and education offering remains robust as changes in regulatory policy from the Trump administration should lead to increased demand for its services."  
• Our Zen Rating model agrees that this is one to watch. With an overall A rating, it belongs to a class of stocks identified as likely to outperform the wider market. In fact, per the 115 factors taken into account by our rating system, Huron Consulting Group stock actually ranks in the 98th percentile of all the equities we track.
• While the stock ranks high in a variety of categories, we have to highlight its Sentiment and Artificial Intelligence (AI) Component Grade ratings. In both categories, Huron Consulting ranks in the 94th percentile. The stock has provided stable returns over the past five years, and machine learning has identified subtle patterns in market data that point to a higher likelihood of continued outperformance. (See all 7 Zen Component Grades here >)

What to Do Next?

• 8 Stock Lists You Need Now >
• See All “A” Rated Stocks with +32.52% Average Annual Return > 
• 4 Step Process to Find More 100%+ Stock Winners >

Want to get in touch? Email us at news@wallstreetzen.com.